Top Bulls Reasons To Buy — Vote below!

Add a New Bulls Reason

Company: ATS Medical (ATSI)
Current price:
Headline: (100 character max)
Analysis:
Cancel
100%
agree
2 votes

  Exploding 10 Billion $ Market

ATS Medical (ATSI) is in play! They make Cryo-Ablation devices used to treat A-Fib...a growing epidemic that roughly 2 out of 10 people will have over a life-time. Three stages of A-Fib..Distole <2-3weeks, Proximal 1 to 2 months, and Chronic pretty much forever until treated. Pharma only takes us so far, the electrical component of The Heart still has to be "fixed" or Ablated< which takes us back to Cryo and ATSI.

ATS Medical Purchased roughly 25% of Cryo-Caths (Another good Investment, along with Cryo-Port) cryo-ablation business. Studies have been excellent from around the world >40,000 patients (not yet entered in US data)

A-Fib begats a-fib (longer you're in it more likely you are to stay) It leads to clotting in your Atriums (Usually The Right) and is one of the main causes of strokes.  This is 10 Billion dollar market.  Current technologies allow the Physician to "burn" the Atrium through RF energy. Once burned you've pasted the point of no return.  But with Cryo you have an exploring element/ability...meaning you can cool the tissue down certain levels allowing different electrical pathways then "kill" later the tissue.  Cryo gives you the ability to change course because tissue will stun then can "thaw out".  To effectively kill the tissue much like RF <400 degrees celcius can be acheived which is more than capable.  Reversal #'s as high as 92%> with less than 10% on expensive rate controlling drugs.

10 Billion dollar market...Limited but Proven statistically significant Research and good management makes ATSI a steal <2.50 selling now for 1.83

(100 character max) Cancel
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki